GWW
69
2
IRM
52
2
KMI
73
2
XRAY
38
-3
ALL
56
3
CL
50
3
DD
40
4
AZO
65
2
ZION
71
2
ACN
56
-5
WFC
82
2
ECL
47
2
GOOG
69
14
TDC
67
-3
KO
52
2
O
37
7
PNR
77
5
UA
48
-8
COST
50
2
LYB
22
2
GWW
69
2
IRM
52
2
KMI
73
2
XRAY
38
-3
ALL
56
3
CL
50
3
DD
40
4
AZO
65
2
ZION
71
2
ACN
56
-5
WFC
82
2
ECL
47
2
GOOG
69
14
TDC
67
-3
KO
52
2
O
37
7
PNR
77
5
UA
48
-8
COST
50
2
LYB
22
2
Financhill
Back

Summit Therapeutics Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
54

SMMT
Summit Therapeutics

Last Price:
$23.88
Seasonality Move:
8.71%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • The current trend is relatively stagnant and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Summit Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 24.06 Sell
20-day SMA: 25.75 Sell
50-day SMA: 22.4 Buy
200-day SMA: 19.54 Buy
8-day EMA: 24.11 Sell
20-day EMA: 24.38 Sell
50-day EMA: 23.14 Buy
200-day EMA: 18.7 Buy

Summit Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 49.39 Sell
Chaikin Money Flow: 1400872 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.31 - 28.63) Sell
Bollinger Bands (100): (17.83 - 24.49) Buy

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Summit Therapeutics Stock

Is Summit Therapeutics Stock a Buy?

SMMT Technical Analysis vs Fundamental Analysis

Buy
54
Summit Therapeutics (SMMT) is a Buy

Is Summit Therapeutics a Buy or a Sell?

Summit Therapeutics Stock Info

Market Cap:
17.7B
Price in USD:
23.87
Share Volume:
1.7M

Summit Therapeutics 52-Week Range

52-Week High:
36.91
52-Week Low:
2.10
Buy
54
Summit Therapeutics (SMMT) is a Buy

Summit Therapeutics Share Price Forecast

Is Summit Therapeutics Stock a Buy?

  • Summit Therapeutics share price is 23.87 while SMMT 8-day exponential moving average is 24.11, which is a Sell signal.
  • The stock price of SMMT is 23.87 while Summit Therapeutics 20-day EMA is 24.38, which makes it a Sell.
  • Summit Therapeutics 50-day exponential moving average is 23.14 while SMMT share price is 23.87, making it a Buy technically.
  • SMMT stock price is 23.87 and Summit Therapeutics 200-day simple moving average is 18.70, creating a Buy signal.

Fundamental Analysis of Summit Therapeutics

Is Summit Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.

Technical Analysis of Summit Therapeutics

Should I short Summit Therapeutics stock?

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.